Clinical Trials Logo

Clinical Trial Summary

Background: Cognitive impairment appears frequently in cancer survivors, negatively affecting the quality of life and emotional well-being of patients. This study compares the effectiveness of a well-established treatment (cognitive rehabilitation) with the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) to alleviate these cognitive deficits and evaluate its effect on anxiety-depressive symptoms and the quality of life of survivors. Methods: A three-arm randomized superiority clinical trial, with a pre-post and follow-up repeated measures and intergroup design with a 1:1:1 allocation ratio will be carried out. A hundred and twenty-three breast cancer survivors with mild to moderate cognitive impairment will be randomly assigned to one of the interventions of the study: cognitive rehabilitation intervention group, an intervention group with UP intervention, or a control group on the waiting list. The primary outcome is to observe a significant improvement in cognitive function and quality of life in both intervention groups and a significant decrease in emotional impairments in comparison with the waitlist group. These results will be maintained at six months of follow-up. Discussion: The aim of this work is to test the efficacy of the Unified Barlow Protocol in reducing cognitive deficits in breast cancer survivors. The results of this trial may be useful in reducing the presence of cognitive problems in survivors and improving their emotional state and quality of life.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05289258
Study type Interventional
Source Universidad de Córdoba
Contact
Status Recruiting
Phase N/A
Start date January 25, 2021
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04416087 - Exercise and Tumor Blood Flow in Breast Cancer Patients N/A
Active, not recruiting NCT04726319 - Family History App in Personalized Medicine N/A
Recruiting NCT05800834 - Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds Phase 2
Completed NCT04692168 - Influence of Chemotherapy on Postural Control in Women With Cancer
Recruiting NCT06152419 - Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project N/A
Recruiting NCT03709134 - Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
Completed NCT03282214 - A Self-Management Energy Conservation Program for Cancer-Related Fatigue Phase 2
Recruiting NCT06275321 - Physical Exercise Benefits for Cancer Patients N/A
Recruiting NCT05711030 - Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery N/A
Suspended NCT03271853 - Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis. N/A
Active, not recruiting NCT03144947 - Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients Phase 2
Completed NCT02996201 - Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial N/A
Recruiting NCT05573022 - Impact of a Patient Decision Aid Intervention N/A
Completed NCT05161312 - A Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients - a Randomised Clinical Trial N/A
Completed NCT04836221 - Comorbidities And Reducing inEquitieS N/A
Recruiting NCT06345534 - FAST-FORWARD vs HAI5 N/A
Recruiting NCT06391749 - Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Enrolling by invitation NCT06409221 - VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study
Not yet recruiting NCT03910283 - Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer N/A
Completed NCT03612934 - The Impact of SPC on Advanced Breast Cancer Patients